Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Pancreas. 2015 May;44(4):583–589. doi: 10.1097/MPA.0000000000000317

Figure 3. NF-κB is constitutively active in pancreatic cancer cell-derived tumors.

Figure 3

Protein lysates from tumors of animals injected with pancreatic cancer cell lines indicated were assessed for the activity of the p50 subunit of NFkB and normalized to protein concentration. *= p ≤ 0.05 vs. KPC1